---
title: "Moleculin Biotech (MBRX.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/MBRX.US/norm.md"
symbol: "MBRX.US"
name: "Moleculin Biotech"
parent: "https://longbridge.com/zh-HK/quote/MBRX.US.md"
datetime: "2026-05-19T20:49:35.580Z"
locales:
  - [en](https://longbridge.com/en/quote/MBRX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MBRX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MBRX.US/norm.md)
---

# Moleculin Biotech (MBRX.US) — 財務報表

## 損益表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -3.54 | 6.90 | -17.02 | -27.28 | -17.22 |
| ROE | -387.16% | -1037.30% | 596.13% | 1940.42% | -855.14% |
| 營業收入 | - | - | - | - | - |
| 凈利潤 | -14.61M | 15.45M | -25.40M | -17.28M | -6.44M |
| 營業利潤 | -7.87M | -7.53M | -5.91M | -5.72M | -5.94M |
| 毛利率 | - | - | - | - | - |
| 凈利率 | - | - | - | - | - |
| 利潤含金量 | - | - | - | - | - |

## 資產負債表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 資產與負債 | 23.36M | 22.13M | 20.35M | 21.59M | 21.01M |
| 權益乘數 | 1.54 | 1.47 | -0.7561 | -3.01 | 500.31 |
| 每股凈資產 | 2.85 | 4.69 | -13.60 | -5.93 | 0.0743 |
| 資產周轉率 | - | - | - | - | - |
| 現金及短投 | 10.32M | 8.88M | 6.70M | 7.56M | 7.72M |
| 存貨與應收 | - | - | - | - | - |
| 長期投資 | 354000.00 | 392000.00 | 420000.00 | 469000.00 | 525000.00 |
| 凈債務 | -10.13M | -8.52M | -6.31M | -7.14M | -7.27M |

## 現金流量表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 經營現金流 | -6.11M | -5.37M | -7.22M | -5.58M | -4.56M |
| 投資現金流 | - | - | - | - | - |
| 融資現金流 | 7.61M | 7.49M | 6.38M | 5.42M | 8.00M |
| 自由現金流 | -3.50M | -2.61M | -5.26M | -2.01M | -2.37M |
| 現金流充裕率 | - | - | - | - | - |
| 舉債與償債 | - | - | - | - | - |
| 資本支出 | - | - | - | - | - |